Table 2.
Sociodemographic and clinical characteristics according to attitude towards treatment
| Positive DAI-10 score (N = 64) | Negative DAI-10 score (N = 22) | P-value | |
|---|---|---|---|
| Age (years), mean (SD) | 42.1 (11.7) | 45.9 (13.0) | 0.201 (T = 1.29) |
| Sex (male), N (%) | 39 (60.9) | 9 (40.9) | 0.103 (χ2 = 2.66) |
| Living status (alone), N (%) | 9 (14.1) | 6 (27.3) | 0.159 (χ2 = 1.98) |
| Marital status (single), N (%) | 48 (78.7) | 17 (87.3) | 0.527 (χ2 = 1.28) |
| Diagnosis, N (%) | 0.026 (χ2 = 4.93) | ||
| Schizophrenia | 29 (45.3) | 16 (72.7) | |
| Bipolar disorder | 35 (54.7) | 6 (27.3) | |
| Duration of illness (years), mean (SD) | 18.1 (13.9) | 19.1 (12.3) | 0.773 (T = −0.29) |
| Number of acute episodes within the last 5 years, mean (SD) | 2.9 (4.4) | 5.0 (5.7) | 0.084 (T = −1.74) |
| Time since the last acute episode (years), mean (SD) | 3.7 (5.7) | 0.9 (0.7) | 0.001 (T = 2.15) |
| Number of hospitalizations, mean (SD) | 4.4 (7.9) | 6.6 (7.2) | 0.276 (T = −1.10) |
| Time since the last hospitalization (years), mean (SD) | 4.5 (6.8) | 0.9 (0.6) | 0.001 (T = 2.18) |
| DAI-10 score, mean (SD) | 4.5 (2.8) | −4.7 (2.7) | 0.001 (T = 13.66) |
| CGI-S score, mean (SD) | 3.3 (1.1) | 3.8 (0.7) | 0.045 (T = −2.03) |
| SUMD score, mean (SD) | 6.6 (2.8) | 10.1 (3.3) | 0.001 (T = −4.73) |
| ROMI, mean (SD) | |||
| Total score | 44.5 (6.1) | 43.6 (5.5) | 0.534 (T = 0.56) |
| Compliance subscale score | 20.3 (2.8) | 16.7 (3.2) | 0.001 (T = 5.01) |
| N on compliance subscale score | 24.2 (5.3) | 26.9 (4.3) | 0.021 (T = −2.21) |
| UKU score | 4.1 (5.9) | 5.0 (6.9) | 0.517 (T = −0.28) |
Note: Patients were grouped according to positive (≥0) or negative (<0) scores on the 10-item DAI.23
Abbreviations: DAI-10, 10-item Drug Attitude Inventory; CGI-S, Clinical Global Impression – Severity scale; SD, standard deviation; SUMD, Scale of Unawareness of Mental Disorders; ROMI, Rating of Medication Influences scale; UKU, Udvalg for Kliniske Undersøgelser Side Effect Rating Scale; T, Student’s t-test; χ2, Chi-squared test.